Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-05

Clinical Trial Update: Efficacy Study of Botox to Treat Neuropathic Pain [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the efficacy of Botox for postherpetic neuralgia and nerve trauma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Hospital Ambroise Paré Paris | Conditions: Postherpetic Neuralgia, Nerve Trauma | Phase 4 | Status: COMPLETED